NHLBI Next Gen - Pulmonary Artery Hypertension (Dr. Marlene Rabinovitch, Stanford University)

Showing 65–70 of 70 results

Cell Line	Cell Line Alias	Cell Type	Disease	Sex	Age at Collection	Ethnicity	Genetically Related Cell Lines	dbGaP Data
STAN032i-48-1	IPSVNOC1	Human iPS	None reported	Female	60 Years	Caucasian	No	No
STAN034i-48-2	IPSVNOC2	Human iPS	None reported	Female	60 Years	Caucasian	No	No
STAN035i-49-1	IPSVNOC1	Human iPS	None reported	Male	25 Years	Caucasian	No	No
STAN036i-49-2	IPSVNOC2	Human iPS	None reported	Male	25 Years	Caucasian	No	No
STAN037i-118-1	IPSVNOC1	Human iPS	Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome	Female	40 Years	Caucasian	No	No
STAN038i-118-2	IPSVNOC2	Human iPS	Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome	Female	40 Years	Caucasian	No	No
STAN039i-119-1	IPSVNOC1	Human iPS	Associated Pulmonary Arterial Hypertension with Lupus and pulmonary fibrosis	Female	40 Years	African American	No	No
STAN040i-119-2	IPSVNOC2	Human iPS	Associated Pulmonary Arterial Hypertension with Lupus and pulmonary fibrosis	Female	40 Years	African American	No	No
STAN041i-122-1	IPSVNOC1	Human iPS	Associated Pulmonary Arterial Hypertension status post and patent ductus arteriosus	Female	14 Years	Caucasian	No	No
STAN042i-122-2	IPSVNOC2	Human iPS	Associated Pulmonary Arterial Hypertension status post and patent ductus arteriosus	Female	14 Years	Caucasian	No	No

1…345…7